PubRank

Myeloid leukemia after cytotoxic therapy and other hematotoxins.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 11086943)

Published in J Toxicol Environ Health A on November 01, 2000

Authors

R A Larson1

Author Affiliations

1: Department of Medicine, Pritzker School of Medicine and Cancer Research Center, University of Chicago, Illinois 60637, USA. rlarson@medicine.bsd.uchicago.edu

Articles citing this ↘

Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia. Blood (2007) 3.73